Prostate cancer not likely to be cause of death in men with low-risk disease
the ONA take:
Relatively unaggressive prostate tumors are not likely to develop into metastatic disease or result in death, according to a study by researchers at the Brady Urological Institute at Johns Hopkins.
The researchers analyzed survival data of 1,298 men enrolled over the past 20 years in an active surveillance program Johns Hopkins. Of the participants, just two men died of prostate cancer, and three developed metastatic disease.
Urologists carefully selected which men were candidates for active surveillance and monitored the participants. Selection was based, in part, on Gleason scores determined by pathologic evaluation of prostate biopsy tissue.
In 1995, when the study began, the men underwent annual biopsy until age 75 years. Annual biopsies are no longer required among those men in the lowest risk group; however, when a biopsy is performed, MRI-guided technology is used and pathologists are asked to check biopsy tissue levels of proteins made by the PTEN gene, a biomarker for prostate cancer aggressiveness.
A benefit of using active surveillance for men who prostate cancer is very low or low-risk is reduction in rates of complications and costs of prostate cancer treatments.
Relatively unaggressive prostate tumors are not likely to develop into metastatic disease or result in death.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|